Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate.
暂无分享,去创建一个
Even Angell-Petersen | Qian Peng | Trond Warloe | Johan Moan | Q. Peng | J. Moan | K. Giercksky | E. Angell‐Petersen | T. Warloe | Karl-Erik Giercksky | A. Soler | R. Sørensen | Roar Sørensen | Ana Maria Soler
[1] Kristian Berg,et al. 5-Aminolevulinic Acid, but not 5-Aminolevulinic Acid Esters, is Transported into Adenocarcinoma Cells by System BETA Transporters , 2000, Photochemistry and photobiology.
[2] J. M. Marchetti,et al. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[3] A. Lucky,et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. , 2003, Journal of the American Academy of Dermatology.
[4] J Moan,et al. On the pharmacokinetics of topically applied 5‐aminolevulinic acid and two of its esters , 2001, International journal of cancer.
[5] K Svanberg,et al. Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. , 1999, Journal of photochemistry and photobiology. B, Biology.
[6] Thomas J. Flotte,et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment , 2004, Archives of Dermatological Research.
[7] H Moseley,et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group , 2002, The British journal of dermatology.
[8] H. Wulf,et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment , 2003, The British journal of dermatology.
[9] A. Stanton,et al. Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry , 2003, The British journal of dermatology.
[10] Jean-Jacques Grob,et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. , 2004, Archives of dermatology.
[11] Joris Kloek,et al. Prodrugs of 5‐Aminolevullinic Acid for Photodynamic Therapy , 1996, Photochemistry and photobiology.
[12] R. M. Szeimiesa,et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .
[13] P Lehmann,et al. Preferential Relative Porphyrin Enrichment in Solar Keratoses upon Topical Application of ^‐Aminolevulinic Acid Methylester , 1998, Photochemistry and photobiology.
[14] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[15] Q. Peng,et al. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. , 1996, Ultrastructural pathology.
[16] H. Sterenborg,et al. Quantification of the hematoporphyrin derivative by fluorescence measurementusing dual-wavelength excitation anddual-wavelength detection. , 1993, Applied optics.
[17] L. Guillou,et al. Fluorescence Photodetection (pd) and Photodynamic Therapy Photodetection of Early Human Bladder Cancer Based on the Fluorescence of 5-aminolaevulinic Acid Hexylester- Induced Protoporphyrin Ix: a Pilot Study , 2022 .
[18] C. Perotti,et al. ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice , 2002, British Journal of Cancer.
[19] N. Bendsøe,et al. Photodynamic therapy and diagnostic measurements of basal cell carcinomas using esterified and non-esterified delta-aminolevulinic acid , 2001 .
[20] Z. Malik,et al. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.
[21] T. Foster,et al. ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids , 2001, British Journal of Cancer.
[22] A. Berner,et al. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. , 1999, Acta dermato-venereologica.
[23] J Moan,et al. A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice. , 1987, Cancer letters.
[24] Stanley B. Brown,et al. Comparative in vitro percutaneous penetration of 5‐aminolevulinic acid and two of its esters through excised hairless mouse skin , 2003, Lasers in surgery and medicine.
[25] J Moan,et al. DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA , 1995, Photochemistry and photobiology.
[26] Q. Peng,et al. 5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.
[27] H Kerl,et al. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.
[28] Q. Peng,et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. , 2001, Journal of photochemistry and photobiology. B, Biology.
[29] J C Kennedy,et al. NON‐INVASIVE TECHNIQUE FOR OBTAINING FLUORESCENCE EXCITATION AND EMISSION SPECTRA IN VIVO , 1986, Photochemistry and photobiology.
[30] Norbert Lange,et al. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. , 2004, Advanced drug delivery reviews.
[31] K. Giercksky,et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. , 2001, The British journal of dermatology.
[32] Hans Christian Wulf,et al. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. , 2003, Archives of dermatology.
[33] J. Kennedy,et al. The Monitoring of ALA-Induced Protoporphyrin IX Accumulation and Clearance in Patients with Skin Lesions by In Vivo Surface-Detected Fluorescence Spectroscopy , 1999, Lasers in Medical Science.
[34] D. Vernon,et al. Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo , 2002, British Journal of Cancer.
[35] H Anholt,et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. , 1997, Cancer research.
[36] A. Berner,et al. Skin scrape cytology in the diagnosis of nodular basal cell carcinoma for treatment by photodynamic therapy. , 1999, Acta dermato-venereologica.
[37] M W Berns,et al. Dosimetry model for photodynamic therapy with topically administered photosensitizers , 1996, Lasers in surgery and medicine.
[38] D. Murrell,et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study , 2003, The Journal of dermatological treatment.
[39] Johan Emelian Moan,et al. Measurements of sensitizer fluorescence in patients by means of an ordinary fluorescence spectrometer , 1994, Other Conferences.
[40] C. Perotti,et al. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization , 2001, British Journal of Cancer.